Esperion Therapeutics | ESPR - Pe Kurs-Gewinn

Aktienkurs
2.59
Täglich Wechseln
0.04 1.37%
Monatlich
-22.60%
Jährlich
52.96%
Q1 Prognose
2.47




Pe Veränderung Datum
AbbVie 24.03 86.23 2025-12
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amarin 91.05 88.3 2023-06
Amgen 25.31 15.82 2025-12
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Cipla 27.74 3.55 2025-12
CSL 16.16 9.59 2025-12
Daiichi Sankyo 20.73 1.74 2025-12
Eli Lilly 40.21 9.66 2025-12
Esperion Therapeutics 129.79 129 2024-12
Grifols 11.2 1.08 2025-12
Halozyme Therapeutics 23.16 7.7 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Sanofi 11.99 1.58 2025-12
Sarepta Therapeutics 27.27 0 2025-09
United Therapeutics 17.32 1.62 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06